481 related articles for article (PubMed ID: 17973543)
1. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.
Irujo M; Beitia G; Bes-Rastrollo M; Figueiras A; Hernández-Díaz S; Lasheras B
Drug Saf; 2007; 30(11):1073-82. PubMed ID: 17973543
[TBL] [Abstract][Full Text] [Related]
2. Influence of pharmacists' attitudes on adverse drug reaction reporting : a case-control study in Portugal.
Herdeiro MT; Figueiras A; Polónia J; Gestal-Otero JJ
Drug Saf; 2006; 29(4):331-40. PubMed ID: 16569082
[TBL] [Abstract][Full Text] [Related]
3. Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey.
Li R; Curtain C; Bereznicki L; Zaidi STR
Int J Clin Pharm; 2018 Aug; 40(4):878-889. PubMed ID: 30097819
[TBL] [Abstract][Full Text] [Related]
4. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
Hajj A; Hallit S; Ramia E; Salameh P;
Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
[TBL] [Abstract][Full Text] [Related]
5. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
[No Abstract] [Full Text] [Related]
6. Adverse drug reaction reporting by community pharmacists-The barriers and facilitators.
Hughes ML; Weiss M
Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1552-1559. PubMed ID: 31131966
[TBL] [Abstract][Full Text] [Related]
7. Community pharmacists' challenges regarding adverse drug reaction reporting: a cross-sectional study.
Paut Kusturica M; Tomas A; Rašković A; Gigov S; Crnobrnja V; Jevtić M; Stilinović N
Curr Med Res Opin; 2022 Jul; 38(7):1229-1236. PubMed ID: 35470747
[TBL] [Abstract][Full Text] [Related]
8. Pharmacists' attitudes toward adverse drug reaction reporting in Hong Kong.
Lee KK; Chan TY; Raymond K; Critchley JA
Ann Pharmacother; 1994 Dec; 28(12):1400-3. PubMed ID: 7696734
[TBL] [Abstract][Full Text] [Related]
9. Community Pharmacists' Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New Zealand.
Barnes J; Butler R
Drug Saf; 2020 Nov; 43(11):1157-1170. PubMed ID: 32975740
[TBL] [Abstract][Full Text] [Related]
10. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
Su C; Ji H; Su Y
Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
[TBL] [Abstract][Full Text] [Related]
12. Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
Kopciuch D; Zaprutko T; Paczkowska A; Ratajczak P; Zielińska-Tomczak Ł; Kus K; Nowakowska E
Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1543-1551. PubMed ID: 31148344
[TBL] [Abstract][Full Text] [Related]
13. Community pharmacists' views on adverse drug reactions reporting in Malaysia: a pilot study.
Ting KN; Stratton-Powell DM; Anderson C
Pharm World Sci; 2010 Jun; 32(3):339-42. PubMed ID: 20336371
[TBL] [Abstract][Full Text] [Related]
14. Adverse drug reactions reporting: pharmacists' knowledge, attitude and practice in Shiraz, Iran.
Afifi S; Maharloui N; Peymani P; Namazi S; Gharaei AG; Jahani P; Lankarani KB
Int J Risk Saf Med; 2014; 26(3):139-45. PubMed ID: 25214159
[TBL] [Abstract][Full Text] [Related]
15. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway.
Granas AG; Buajordet M; Stenberg-Nilsen H; Harg P; Horn AM
Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):429-34. PubMed ID: 16953518
[TBL] [Abstract][Full Text] [Related]
16. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran.
Vessal G; Mardani Z; Mollai M
Pharm World Sci; 2009 Apr; 31(2):183-7. PubMed ID: 19116770
[TBL] [Abstract][Full Text] [Related]
17. Community pharmacists' attitudes, perceptions, and barriers toward adverse drug reaction reporting in Malaysia: a quantitative insight.
Elkalmi RM; Hassali MA; Ibrahim MI; Jamshed SQ; Al-Lela OQ
J Patient Saf; 2014 Jun; 10(2):81-7. PubMed ID: 24618640
[TBL] [Abstract][Full Text] [Related]
18. Cross-sectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, Bangladesh.
Amin MN; Khan TM; Dewan SM; Islam MS; Moghal MR; Ming LC
BMJ Open; 2016 Aug; 6(8):e010912. PubMed ID: 27489151
[TBL] [Abstract][Full Text] [Related]
19. Views of British community pharmacists on direct patient reporting of adverse drug reactions (ADRs).
Krska J
Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1130-3. PubMed ID: 22729956
[TBL] [Abstract][Full Text] [Related]
20. Adverse Drug Reaction Monitoring and Reporting Among Physicians and Pharmacists in Pakistan: A Cross-sectional Study.
Nisa ZU; Zafar A; Zafar F; Pezaro S; Sher F
Curr Drug Saf; 2020; 15(2):137-146. PubMed ID: 32338223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
